| Period Ending | Mar 1, 2013 | Nov 30, 2012 | Aug 31, 2012 | Jun 1, 2012 |
|---|
|
Total Revenue
|
442,682
|
296,623
|
385,011
|
319,049
| | Cost of Revenue | 287,237 | 206,833 | 250,461 | 214,390 | | |
Gross Profit
|
155,445
|
89,790
|
134,550
|
104,659
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 94,879 | 91,447 | 94,711 | 84,846 |
|
Non Recurring | 5,843 | 1 | 325 | 95 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
54,723
|
(1,658)
|
39,514
|
19,718
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 31 | 38 | 58 | 71 |
|
Earnings Before Interest And Taxes | 54,754 | (1,620) | 39,572 | 19,789 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 54,754 | (1,620) | 39,572 | 19,789 |
|
Income Tax Expense | 21,281 | (811) | 15,136 | 7,708 |
|
Minority Interest | 856 | 702 | 537 | 197 |
|
|
|
Net Income From Continuing Ops | 32,037 | (107) | 24,973 | 12,278 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
34,329
|
(107)
|
24,973
|
12,278
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
34,329
|
(107)
|
24,973
|
12,278
|
|
0.05(0.23%) 10:13AM EDT - Nasdaq Real Time Price